Sana Health’s CEO, Richard Hanbury, participated in a panel discussion at SOCAP 2022. This panel discussed what it means to be an early-stage company in the disability market, problems addressed by their products, why these solutions are designed to be additive to the overall tech market and why the disability market has tremendous potential to drive both profits and purpose, returning value to investors and society.
https://socapglobal.com/events/socap22/
The Sana device is not currently approved for use for treatment of medical conditions and should be used for the purposes of rest and recovery in healthy adults, until such time as appropriate clinical evidence is approved through FDA processes. Use of the Sana device for purposes other than enhanced rest and recovery in healthy adults is not approved or recommended.